Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Editor's Recommendations
Most Read Articles
22 Jan 2018
In a symposium chaired by Dr Yoon-Sim Yap of the National Cancer Centre Singapore, renowned regional and international experts in the field of breast cancer, Dr Yen-Shen Lu from Taiwan and Professor Nadia Harbeck from Germany, joined her in providing insights on the current treatment landscape of hormone receptor-positive (HR+) advanced breast cancer. In their respective sessions, they each highlighted new therapeutic options including the optimal use of dual blockade therapy for oestrogenreceptor-positive (ER+) advanced breast cancer for patients in Asia. 
Jenny Ng, 08 Jan 2015
A second set of Choosing Wisely recommendations developed by the American Society of Hematology (ASH) were presented at the 56th ASH Annual Meeting & Exposition. The following list adds to the previous five tests, treatments and procedures that should be questioned by clinicians and patients under specific, indicated circumstances. [Blood 2014;124:3524-3528]
Christina Lau, 13 Feb 2015
The US FDA granted accelerated approval to palbociclib, a cyclin-dependent kinase (CDK) 4/6 inhibitor, as first-line endocrine therapy for postmenopausal women with oestrogen receptor (ER)-positive, HER2-negative metastatic breast cancer.